Bradley P J
Department of Otorhinolaryngology--Head and Neck Surgery, Queens Medical Centre, Nottingham, UK.
ORL J Otorhinolaryngol Relat Spec. 2001 Jul-Aug;63(4):233-42. doi: 10.1159/000055748.
Patients who present with malignant salivary glands should at their initial assessment have an X-ray of the chest to exclude the possibility of distant metastases. Patients who have other symptoms, bone pain etc., should be appropriately investigated. The likelihood of patients developing distant metastases is associated with high-grade tumors, most commonly adenoid cystic carcinoma, high-grade mucoepidermoid carcinoma, salivary duct carcinoma and tumors sited in the submandibular gland, posterior tongue and pharyngeal tumors. Patients who have had a high-grade tumor treated and survived without locoregional recurrence have the same risk of developing distant metastases as those patients who have locoregional recurrence. Other histological types of salivary tumors are associated with a lower risk of developing distant metastases but a real risk remains lifelong. It is recommended that all patients who have a malignant salivary gland tumor treated, any histology, should be followed up and clinically assessed at least once every 12 months for life.
出现恶性唾液腺肿瘤的患者在初次评估时应进行胸部X光检查,以排除远处转移的可能性。有其他症状(如骨痛等)的患者应进行适当的检查。患者发生远处转移的可能性与高级别肿瘤相关,最常见的是腺样囊性癌、高级别黏液表皮样癌、涎腺导管癌以及位于下颌下腺、舌后部和咽部的肿瘤。接受过高级别肿瘤治疗且无局部区域复发而存活的患者发生远处转移的风险与有局部区域复发的患者相同。其他组织学类型的唾液腺肿瘤发生远处转移的风险较低,但终生都存在实际风险。建议所有接受过恶性唾液腺肿瘤治疗的患者,无论组织学类型如何,都应进行随访,并在一生中至少每12个月进行一次临床评估。